SE439159B - Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat - Google Patents

Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat

Info

Publication number
SE439159B
SE439159B SE7608306A SE7608306A SE439159B SE 439159 B SE439159 B SE 439159B SE 7608306 A SE7608306 A SE 7608306A SE 7608306 A SE7608306 A SE 7608306A SE 439159 B SE439159 B SE 439159B
Authority
SE
Sweden
Prior art keywords
fluoropyrimidin
derivatives
procedure
preparing new
preparing
Prior art date
Application number
SE7608306A
Other languages
English (en)
Swedish (sv)
Other versions
SE7608306L (sv
Inventor
M Yasumoto
J Yamashita
I Yamawaki
N Unemi
S Hashimoto
K Kitazato
S Fujii
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50150936A external-priority patent/JPS6011032B2/ja
Priority claimed from JP15093775A external-priority patent/JPS6011033B2/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of SE7608306L publication Critical patent/SE7608306L/xx
Publication of SE439159B publication Critical patent/SE439159B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7608306A 1975-12-16 1976-07-21 Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat SE439159B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50150936A JPS6011032B2 (ja) 1975-12-16 1975-12-16 ２―置換―５―フルオルピリミジン―４―オン誘導体の製造法
JP15093775A JPS6011033B2 (ja) 1975-12-16 1975-12-16 ５‐フルオルピリミジン―４―オン誘導体の製造法

Publications (2)

Publication Number Publication Date
SE7608306L SE7608306L (sv) 1977-06-17
SE439159B true SE439159B (sv) 1985-06-03

Family

ID=26480366

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608306A SE439159B (sv) 1975-12-16 1976-07-21 Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat

Country Status (12)

Country Link
US (1) US4080455A (xx)
AU (1) AU505440B2 (xx)
CA (1) CA1063606A (xx)
CH (2) CH621544A5 (xx)
DE (1) DE2633359C3 (xx)
DK (1) DK137957B (xx)
FI (1) FI61885C (xx)
FR (1) FR2335228A1 (xx)
GB (1) GB1501537A (xx)
NL (1) NL162643C (xx)
NO (1) NO143903C (xx)
SE (1) SE439159B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68935B (xx) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) * 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
CN101955465B (zh) * 2010-09-29 2012-07-04 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物及其制备方法和应用
CN102532039B (zh) * 2010-09-29 2014-03-26 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物在制备抗肿瘤药物中的应用
CN102659689B (zh) * 2012-05-16 2014-12-17 浙江工业大学 4-取代-2-丁氧基-5-氟嘧啶类化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802005A (en) * 1957-08-06 S-eluorourace
US3784693A (en) * 1972-10-18 1974-01-08 Sandoz Ag 3-substituted phenyl-quinazoline-4(3h)-ones as sedative hypnotics
CH579057A5 (xx) * 1973-09-07 1976-08-31 Hoffmann La Roche

Also Published As

Publication number Publication date
FI762166A (xx) 1977-06-17
DE2633359B2 (de) 1980-12-04
DK137957B (da) 1978-06-12
SE7608306L (sv) 1977-06-17
DE2633359C3 (de) 1981-12-17
NL162643C (nl) 1980-06-16
DE2633359A1 (de) 1977-06-30
NL7608537A (nl) 1977-06-20
FI61885C (fi) 1982-10-11
FR2335228B1 (xx) 1978-11-17
CA1063606A (en) 1979-10-02
AU505440B2 (en) 1979-11-22
FI61885B (fi) 1982-06-30
GB1501537A (en) 1978-02-15
AU1547576A (en) 1978-01-05
DK137957C (xx) 1978-11-06
NL162643B (nl) 1980-01-15
FR2335228A1 (fr) 1977-07-15
CH625230A5 (xx) 1981-09-15
NO762664L (xx) 1977-06-17
DK346176A (xx) 1977-06-17
NO143903B (no) 1981-01-26
NO143903C (no) 1981-05-06
US4080455A (en) 1978-03-21
CH621544A5 (xx) 1981-02-13

Similar Documents

Publication Publication Date Title
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE445923B (sv) Forfarande for framstellning av glukosaminderivat
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE7600139L (sv) Nya vifenyloxiderivat
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE431539B (sv) Analogiforfaranden for framstellning av nya bensylalkoholderivat
SE423902B (sv) Forfarande for framstellning av purinderivat
SE420493B (sv) Forfarande for framstellning av nya xantinderivat
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7703634L (sv) Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE422794B (sv) Forfarande for framstellning av basiskt substituerade naftalenderivat
SE7612565L (sv) Forfarande for framstellning av nya rifamycinforeningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7608306-2

Effective date: 19910211

Format of ref document f/p: F